216 related articles for article (PubMed ID: 28833982)
21. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
Lim L; Wei Y; Lu Y; Song J
PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
[TBL] [Abstract][Full Text] [Related]
22. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain.
Babinchak WM; Haider R; Dumm BK; Sarkar P; Surewicz K; Choi JK; Surewicz WK
J Biol Chem; 2019 Apr; 294(16):6306-6317. PubMed ID: 30814253
[TBL] [Abstract][Full Text] [Related]
23. Characterizing TDP-43
Laos V; Do TD; Bishop D; Jin Y; Marsh NM; Quon B; Fetters M; Cantrell KL; Buratto SK; Bowers MT
ACS Chem Neurosci; 2019 Sep; 10(9):4112-4123. PubMed ID: 31430111
[TBL] [Abstract][Full Text] [Related]
24. ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.
Conicella AE; Zerze GH; Mittal J; Fawzi NL
Structure; 2016 Sep; 24(9):1537-49. PubMed ID: 27545621
[TBL] [Abstract][Full Text] [Related]
25. Exploring the aggregation-prone regions from structural domains of human TDP-43.
Kumar V; Wahiduzzaman ; Prakash A; Tomar AK; Srivastava A; Kundu B; Lynn AM; Imtaiyaz Hassan M
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):286-296. PubMed ID: 30315897
[TBL] [Abstract][Full Text] [Related]
26. A complex network of interdomain interactions underlies the conformational ensemble of monomeric TDP-43 and modulates its phase behavior.
Mohanty P; Rizuan A; Kim YC; Fawzi NL; Mittal J
Protein Sci; 2024 Feb; 33(2):e4891. PubMed ID: 38160320
[TBL] [Abstract][Full Text] [Related]
27. ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain.
Dang M; Song J
Biochem Biophys Res Commun; 2020 Apr; 524(2):459-464. PubMed ID: 32007267
[TBL] [Abstract][Full Text] [Related]
28. Protein folding alterations in amyotrophic lateral sclerosis.
Parakh S; Atkin JD
Brain Res; 2016 Oct; 1648(Pt B):633-649. PubMed ID: 27064076
[TBL] [Abstract][Full Text] [Related]
29. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.
Romano V; Quadri Z; Baralle FE; Buratti E
Prion; 2015; 9(1):1-9. PubMed ID: 25635624
[TBL] [Abstract][Full Text] [Related]
30. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
[TBL] [Abstract][Full Text] [Related]
31. Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis.
Chen AK; Lin RY; Hsieh EZ; Tu PH; Chen RP; Liao TY; Chen W; Wang CH; Huang JJ
J Am Chem Soc; 2010 Feb; 132(4):1186-7. PubMed ID: 20055380
[TBL] [Abstract][Full Text] [Related]
32. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
33. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
35. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
Smethurst P; Sidle KC; Hardy J
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
[TBL] [Abstract][Full Text] [Related]
36. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
[TBL] [Abstract][Full Text] [Related]
37. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
38. An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties.
Mollasalehi N; Francois-Moutal L; Scott DD; Tello JA; Williams H; Mahoney B; Carlson JM; Dong Y; Li X; Miranda VG; Gokhale V; Wang W; Barmada SJ; Khanna M
ACS Chem Biol; 2020 Nov; 15(11):2854-2859. PubMed ID: 33044808
[TBL] [Abstract][Full Text] [Related]
39. Protein disulfide isomerase-immunopositive inclusions in patients with amyotrophic lateral sclerosis.
Honjo Y; Kaneko S; Ito H; Horibe T; Nagashima M; Nakamura M; Fujita K; Takahashi R; Kusaka H; Kawakami K
Amyotroph Lateral Scler; 2011 Nov; 12(6):444-50. PubMed ID: 21745122
[TBL] [Abstract][Full Text] [Related]
40. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
